[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Indexing Sources::
Guide for Authors::
Online Submission::
Ethics::
Articles archive::
For Reviewers::
Contact us::
::
Basic and Clinical Biochemistry and Nutrition
..
DOAJ
..
CINAHL
..
EBSCO
..
IMEMR
..
ISC
..
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
enamad
..
:: Volume 24, Issue 1 (Bimonthly 2020) ::
Feyz 2020, 24(1): 31-37 Back to browse issues page
The cytotoxic effects of Tolmetin on evaluation of Bax and Bcl2 genes expression level in cervical cancer cells (Hela)
Sanaz Norouzi , Rahim Ahmadi , Sanaz Pashapour
Department of Biology, Faculty of Basic Sciences, Hamedan Branch, Islamic Azad University, Hamedan, I.R. Iran. , drrahahmadi@yahoo.com
Abstract:   (2188 Views)
Background: Tolmetin (C15H15NO3) is a non-steroidal anti-inflammatory drug that exerts its effects by inhibiting prostaglandins and mainly used in the treatment of acute and chronic arthritis, osteoarthritis, and arthritis. Studies have shown that Tolmetin has anti-carcinogenic effects on different cancer cells. Due to the limited studies on the apoptotic effects of Tolmetin, the present study aimed to evaluate the cytotoxic effects of Tolmetin on the evaluation of Bax and Bcl2 gene expression levels in cervical cancer cells (Hela).
Materials and Methods: In this experimental study, the cervical cancer cells were purchased from Pasteur Institute then randomly divided into control group (non-exposure to Tolmetin) and groups exposed to different concentrations of 0.3, 0.6, 1.25, 2.5, 5 and 10 mg/ml of Tolmetin. The cytotoxic effect of Tolmetin was measured using the MTT assay. Also, using Real-Time PCR, expression of BAX, and BCl2 genes was evaluated. Data were analyzed using one-way ANOVA.
Results: The concentrations of 0.3, 0.6, 1.25, 2.5, 5, and 10 mg/ml of Tolmetin resulted in cytotoxic effects on Hela cells. And IC50 dose of 5 mg/ml of Tolmetin increased the expression of the apoptotic Bax gene more than the anti-apoptotic BCL2 gene.
Conclusion: Tolmetin can possibly cause cell death in cervical cancer cells by inducing the Bax gene and the BCL2 anti-apoptosis gene.
Keywords: Tolmetin, Apoptosis, Bax gene, BCl2 gene
Full-Text [PDF 341 kb]   (841 Downloads)    
Type of Study: Research | Subject: General
Received: 2019/08/3 | Revised: 2020/05/12 | Accepted: 2020/01/18 | Published: 2020/05/16
References
1. Mahmoodi P, Fani M, Rezayi M, Avan A, Pasdar Z, Karimi E, et al. Early detection of cervical cancer based on high‐risk HPV DNA‐based genosensors: A systematic review. Biofactors 2019; 45(2): 101-17.
2. Koh WJ, Abu-Rustum NR, Bean S, Bradley K, Campos SM, Cho KR, et al. Cervical cancer, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 2019; 17(1): 64-84.
3. Riahi S, Mokhtari AM, Vali M, Abdzadeh E, Mohseni S, Salehiniya H, et al. The incidence and mortality rate of cervix cancer in Iran from 1990 to 2016: A systematic review and meta-analysis Running title: Cervix cancer in Iran. J Contemp Med Sci 2019; 5(1): 315-20.
4. Taib S, Ismail N, Mat SN, Shah SA. A Systematic review on factors associated with cervical cancer screening among immigrant women. Int J Pub Hea Cli Sci 2019; 6(1): 22-33.
5. Sekhon S, Kuroki L, Colditz G. Do cancer survivors understand their risk factors for recurrence and the value of coordinated care between an oncologist and a primary care physician? A survey of endometrial and cervical cancer patients. J Clin Transl Sci 2019; 3(1): 121-7.
6. Fokdal L, Tanderup K, Pötter R, Sturdza A, Kirchheiner K, Chargari C, et al. Risk Factors for Ureteral Stricture After Radiochemotherapy Including Image Guided Adaptive Brachytherapy in Cervical Cancer: Results From the EMBRACE Studies. Int J Rad Onc Bio Phy 2019; 103(4): 887-94.
7. Wu J, Ye T, Lv J, He Z, Zhu J. Laparoscopic nerve-sparing radical hysterectomy vs laparoscopic radical hysterectomy in cervical cancer: a systematic review and meta-analysis of clinical efficacy and bladder dysfunction. J Min Inv Gyn 2019; 26(3): 417-26. e6.
8. Prasher P, Mudila H, Sharma M, Khati B. Developmental perspectives of the drugs targeting enzyme-instigated inflammation: a mini review. Med Chem Res 2019; 28(4): 417-49.
9. Jenkins R, Hibberd M. Novel pharmaceutical uses. Google Patents 2019; 20(2): 312-316
10. Küçükgüzel ŞG, Koç D, Çıkla‐Süzgün P, Özsavcı D, Bingöl‐Özakpınar Ö, Mega‐Tiber P, et al. Synthesis of Tolmetin Hydrazide–Hydrazones and Discovery of a Potent Apoptosis Inducer in Colon Cancer Cells. Archiv Der Pharmazie 2015; 348(10): 730-42.
11. Dangi AK, Sinha R, Dwivedi S, GUPTA SK, Shukla PS. Cell line techniques and gene editing tools for antibody production: A review. Front Pharmacol 2018; 26(9): 630.
12. Liu T, Liang H, Liu L, Gong Y, Ding Y, Liao G, et al. Influence of pristine and hydrophobic ZnO nanoparticles on cytotoxicity and endoplasmic reticulum (ER) stress-autophagy-apoptosis gene expression in A549-macrophage co-culture. Ecotoxicol Environ Saf 2019; 167(1): 188-95.
13. Schuetz JM, Grundy A, Lee DG, Lai AS, Kobayashi LC, Richardson H, et al. Genetic variants in genes related to inflammation, apoptosis and autophagy in breast cancer risk. PloS one 2019; 14(1): 812-6.
14. Ghosh AK. Anti-cancer agents and preparation thereof. Google Patents 2019; 12(6): 314-18.
15. La CV, Tavani A, Garattini S. Adverse effects of preventive therapy in humans. IARC Sci Publ 1996(139): 135-42.
16. Tomisato W, Tanaka K-i, Katsu T, Kakuta H, Sasaki K, Tsutsumi S, et al. Membrane permeabilization by non-steroidal anti-inflammatory drugs. Biochem Biophys Res Commu 2004; 323(3): 1032-9.
17. Neill AS, Nagle CM, Protani MM, Obermair A, Spurdle AB, Webb PM, et al. Aspirin, nonsteroidal anti‐inflammatory drugs, paracetamol and risk of endometrial cancer: A case–control study, systematic review and meta‐analysis. Int J Cancer 2013; 132(5): 1146-55.
18. Seely D, Wu P, Fritz H, Kennedy DA, Tsui T, Seely AJ, et al. Melatonin as adjuvant cancer care with and without chemotherapy: a systematic review and meta-analysis of randomized trials. Integr Cancer Ther 2012; 11(4): 293-303.
19. Grabosch SM, Shariff OM, Wulff JL, Helm CW. Non‐steroidal anti‐inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasia. Cochrane Database Syst Rev 2014; 10(4): 2015-220.
20. Fong W, To KK. Drug repurposing to overcome resistance to various therapies for colorectal cancer. Cell Mol Life Sci 2019; 20(6): 1-24.
21. Wong RS. Role of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Cancer Prevention and Cancer Promotion. Adv Pharmacol Sci 2019; 32(6): 1-9.
22. Qi L, Ye J, Xue W, Tian X, Zhang H. The mechanism of aspirin combined with metformin induced apoptosis of thyroid cancer TPC-1 cells. Chi jou onc 2019; 41(4): 276-81.
23. Bigdeli R, Shahnazari M, Panahnejad E, Cohan RA, Dashbolaghi A, Asgary V. Cytotoxic and apoptotic properties of silver chloride nanoparticles synthesized using Escherichia coli cell-free supernatant on human breast cancer MCF 7 cell line. Artif Cells Nanomed Biotechnol 2019; 47(1): 1603-9.
24. Rong Z, Xu Y, Zhang C, Xiang D, Li X, Liu D. Evaluation of intestinal absorption of amtolmetin guacyl in rats: breast cancer resistant protein as a primary barrier of oral bioavailability. Life Sci 2013; 92(3): 245-51.
25. Bellosillo B, Piqué M, Barragán M, Castaño E, Villamor N, Colomer D, et al. Aspirin and salicylate induce apoptosis and activation of caspases in B-cell chronic lymphocytic leukemia cells. Blood 1998; 92(4): 1406-14.
26. He Q, Luo X, Huang Y, Sheikh MS. Apo2L/TRAIL differentially modulates the apoptotic effects of sulindac and a COX-2 selective non-steroidal anti-inflammatory agent in Bax-deficient cells. Oncogene 2002; 21(39): 6032-26.
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Norouzi S, Ahmadi R, Pashapour S. The cytotoxic effects of Tolmetin on evaluation of Bax and Bcl2 genes expression level in cervical cancer cells (Hela). Feyz 2020; 24 (1) :31-37
URL: http://feyz.kaums.ac.ir/article-1-3950-en.html


Creative Commons License
This open access journal is licensed under a Creative Commons Attribution-NonCommercial ۴.۰ International License. CC BY-NC ۴. Design and publishing by Kashan University of Medical Sciences.
Copyright ۲۰۲۳© Feyz Medical Sciences Journal. All rights reserved.
Volume 24, Issue 1 (Bimonthly 2020) Back to browse issues page
مجله علوم پزشکی فیض Feyz Medical Sciences Journal
Persian site map - English site map - Created in 0.05 seconds with 46 queries by YEKTAWEB 4645